Although not statistically significant, the dose normalized AUC was 37.7% greater and clearance 47.5% lower in LDLT as compared with DDLT. An initial tacrolimus dose reduction of about 30-40% may be prudent in LDLT compared with DDLT recipients.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2008) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: